Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
40,880,375
-
Share change
-
+8,709,779
-
Total reported value
-
$6,898,518,442
-
Put/Call ratio
-
101%
-
Price per share
-
$168.77
-
Number of holders
-
925
-
Value change
-
+$1,481,158,937
-
Number of buys
-
437
-
Number of sells
-
261
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2025
As of 31 Dec 2025,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
925 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,880,375 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, CITIGROUP INC, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, TWO SIGMA INVESTMENTS, LP, ENVESTNET ASSET MANAGEMENT INC, GOLDMAN SACHS GROUP INC, RAYMOND JAMES FINANCIAL INC, LPL Financial LLC, and UBS Group AG.
This page lists
925
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.